🧬

Epithalon

Longevity Protocol

10mg × 10 vials — Longevity & Anti-Aging

10 vials — 12 months supply

One of the most discussed anti-aging peptides. Top tier longevity compound with compelling telomere research.

$230

= $0.63/day

Cart

What it does

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase — the enzyme responsible for maintaining telomere length. Telomeres shorten with each cell division, and their length is directly correlated with biological aging. Epithalon also stimulates melatonin production in the pineal gland.

By reactivating telomerase in somatic cells, Epithalon addresses one of the fundamental mechanisms of cellular aging — telomere attrition.

Dosage & Protocol

Subcutaneous injection. 5-10mg/day for 10-20 day cycles, repeated 2-3 times per year. 10 vials at 10mg provides multiple cycles over 12+ months.

Duration

12 months

Format

10-vial protocol box

Purity

99%+ (CoA verified)

Delivery

7-14 days worldwide

What to expect

Day 1-5: Improved sleep quality (melatonin regulation). More vivid dreams.

Day 5-10: Enhanced sense of wellbeing. Better energy. Improved skin quality.

Day 10-20: Cycle completion. Telomerase activation is cumulative — anti-aging benefit is at the cellular level.

Post-cycle: Benefits persist between cycles. Recommended 2-3 cycles per year.

Who it's for

Longevity researchers focused on cellular aging and telomere biology

Biohackers running anti-aging protocols

Those interested in pineal gland function and melatonin optimisation

Researchers studying the intersection of sleep quality and aging

📖

Read the full Epithalon profile in the Peptide Bible

Dosing protocols, stacking guides, safety data, and research references.

Browse Bible

The research

📄

Telomerase activation and telomere elongation (33.3% average increase) in human cells(12937682)

📄

2025 study confirming telomere length increase through telomerase upregulation(PMC12411320)

📄

Human cohort study: 1.6-1.8x mortality reduction over 6 years with Epithalamin treatment(Khavinson-cohort)

Safety notes

⚠️Generally well tolerated with decades of research history.

⚠️Cancer concern: Telomerase activation theoretically could promote cancer — but no evidence in studies, and mortality data actually shows protective effect.

⚠️Best studied in Russian literature. Developed by Professor Vladimir Khavinson.